{"id":7526,"date":"2026-03-19T10:16:05","date_gmt":"2026-03-19T08:16:05","guid":{"rendered":"https:\/\/www.schooler.org.ua\/uk-uabezshumni-ataki-na-nirki-novi-metodi-likuvannja-vimagajut\/"},"modified":"2026-03-19T10:16:05","modified_gmt":"2026-03-19T08:16:05","slug":"uk-uabezshumni-ataki-na-nirki-novi-metodi-likuvannja-vimagajut","status":"publish","type":"post","link":"https:\/\/www.schooler.org.ua\/id\/uk-uabezshumni-ataki-na-nirki-novi-metodi-likuvannja-vimagajut\/","title":{"rendered":"Tich\u00e9 \u00fatoky na ledviny: Nov\u00e1 l\u00e9\u010dba vy\u017eaduje v\u010dasnou detekci IgA nefropatie"},"content":{"rendered":"

U mnoh\u00fdch onemocn\u011bn\u00ed ledvin postupuje ti\u0161e po mnoho let a \u010dasto z\u016fst\u00e1v\u00e1 neodhaleno, dokud nedojde k nevratn\u00e9mu po\u0161kozen\u00ed. Rostouc\u00ed mno\u017estv\u00ed d\u016fkaz\u016f nazna\u010duje, \u017ee v\u010dasn\u00e1 diagnostika a intervence u IgA nefropatie (IgAN), autoimunitn\u00edho onemocn\u011bn\u00ed ledvin, m\u016f\u017ee dramaticky zm\u011bnit v\u00fdsledky pacient\u016f. Ned\u00e1vn\u00e9 pr\u016flomy v c\u00edlen\u00fdch terapi\u00edch \u010din\u00ed v\u010dasnou detekci nejen u\u017eite\u010dnou, ale potenci\u00e1ln\u011b i \u017eivot zachra\u0148uj\u00edc\u00ed. <\/p>\n

Skryt\u00e1 hrozba: Jak IgAN po\u0161kozuje ledviny<\/h3>\n

IgAN naru\u0161uje schopnost ledvin spr\u00e1vn\u011b filtrovat krev. Typicky protil\u00e1tkov\u00fd protein imunoglobulin A (IgA) chr\u00e1n\u00ed p\u0159ed patogeny. U lid\u00ed s IgAN v\u0161ak defektn\u00ed verze IgA spou\u0161t\u00ed imunitn\u00ed odpov\u011b\u010f, kter\u00e1 napad\u00e1 filtra\u010dn\u00ed syst\u00e9m ledvin, glomeruly. Tyto z\u00e1chvaty zp\u016fsobuj\u00ed z\u00e1n\u011bt, zjizven\u00ed a nakonec selh\u00e1n\u00ed ledvin. <\/p>\n

Z\u00e1ludn\u00e1 \u010d\u00e1st IgAN je jeho tich\u00e1 progrese.<\/strong> Pacienti \u010dasto z\u016fst\u00e1vaj\u00ed cel\u00e9 roky nev\u011bdom\u00ed, dokud se v mo\u010di neobjev\u00ed krev (\u010dasto po virov\u00e9 infekci) nebo se nezjist\u00ed pokro\u010dil\u00e9 po\u0161kozen\u00ed ledvin. V tomto okam\u017eiku m\u016f\u017ee a\u017e 40 % vy\u017eadovat dial\u00fdzu nebo transplantaci. <\/p>\n

Diagnostick\u00e9 bari\u00e9ry a m\u011bn\u00edc\u00ed se doporu\u010den\u00ed<\/h3>\n

Po desetilet\u00ed se diagnostika IgAN op\u00edrala o invazivn\u00ed biopsii ledvin, postup, p\u0159i kter\u00e9m jehla odeb\u00edr\u00e1 vzorky tk\u00e1n\u011b pro mikroskopickou anal\u00fdzu. Mnoho l\u00e9ka\u0159\u016f v\u00e1halo s biopsi\u00ed pacient\u016f s m\u00edrn\u00fdmi p\u0159\u00edznaky, proto\u017ee mo\u017enosti l\u00e9\u010dby byly doned\u00e1vna omezen\u00e9. Bez potvrzen\u00ed byli pacienti \u010dasto \u0161patn\u011b diagnostikov\u00e1ni s chronick\u00fdm onemocn\u011bn\u00edm ledvin, co\u017e oddalovalo \u00fa\u010dinnou intervenci. <\/p>\n

Zve\u0159ejn\u011bn\u00e9 odhady se zna\u010dn\u011b li\u0161\u00ed (od 0,06 do 4,2 p\u0159\u00edpad\u016f na 100 000 lid\u00ed), \u010d\u00e1ste\u010dn\u011b proto, \u017ee mnoho p\u0159\u00edpad\u016f z\u016fst\u00e1v\u00e1 neodhaleno. Odborn\u00edci se domn\u00edvaj\u00ed, \u017ee genetick\u00e9 faktory ovliv\u0148uj\u00ed riziko, p\u0159i\u010dem\u017e vy\u0161\u0161\u00ed prevalence je u v\u00fdchodn\u00edch Asiat\u016f a ni\u017e\u0161\u00ed u Afroameri\u010dan\u016f. <\/p>\n

M\u011bn\u00ed se diagnostick\u00fd standard. D\u0159\u00edve byly biopsie doporu\u010dov\u00e1ny pouze u pacient\u016f s vysokou hladinou b\u00edlkovin v mo\u010di (jeden gram nebo v\u00edce denn\u011b). Ned\u00e1vn\u00e9 studie v\u0161ak nazna\u010duj\u00ed, \u017ee pacienti se st\u0159edn\u00edmi hladinami (0,5\u20131,0 gramu) \u010del\u00ed v\u00fdznamn\u00e9mu riziku selh\u00e1n\u00ed ledvin do 10 let. Aktualizovan\u00e9 pokyny nyn\u00ed navrhuj\u00ed biopsii pro ty, kte\u0159\u00ed vylu\u010duj\u00ed pouze 0,5 gramu b\u00edlkovin denn\u011b. N\u011bkte\u0159\u00ed nefrologov\u00e9 obhajuj\u00ed je\u0161t\u011b ni\u017e\u0161\u00ed prahov\u00e9 hodnoty, jejich\u017e c\u00edlem je hladina pod 300 miligram\u016f. <\/p>\n

Vzestup c\u00edlen\u00e9 terapie<\/h3>\n

Nedostatek \u00fa\u010dinn\u00e9 l\u00e9\u010dby historicky br\u00e1nil v\u010dasn\u00e9mu odhalen\u00ed. Jedinou mo\u017enost\u00ed byly agresivn\u00ed imunosupresiva se z\u00e1va\u017en\u00fdmi ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky a n\u00edzkou adherenc\u00ed k l\u00e9\u010db\u011b. Nicm\u00e9n\u011b partnerstv\u00ed ve\u0159ejn\u00e9ho a soukrom\u00e9ho sektoru mezi Americkou nefrologickou spole\u010dnost\u00ed a FDA vedlo k rychl\u00e9mu schvalov\u00e1n\u00ed l\u00e9k\u016f IgAN, co\u017e povzbuzuje farmaceutick\u00e9 spole\u010dnosti, aby investovaly do v\u00fdzkumu. <\/p>\n

V\u00fdsledek? Do\u0161lo k prudk\u00e9mu n\u00e1r\u016fstu nov\u00fdch terapi\u00ed zam\u011b\u0159en\u00fdch na z\u00e1kladn\u00ed imunologick\u00e9 mechanismy IgAN. Pat\u0159\u00ed sem:<\/p>\n

    \n
  • Budesonid (Tarpeyo):<\/strong> Steroid, kter\u00fd potla\u010duje defektn\u00ed produkci IgA ve st\u0159evech a sni\u017euje z\u00e1n\u011bt v ledvin\u00e1ch. Jeho lokalizovan\u00e9 p\u016fsoben\u00ed minimalizuje syst\u00e9mov\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky. <\/li>\n
  • Sibeprenlimab (Voyxact):<\/strong> Nov\u00fd l\u00e9k, kter\u00fd blokuje protein APRIL, kter\u00fd nadm\u011brn\u011b stimuluje produkci IgA b\u011bhem infekc\u00ed. Inhibic\u00ed APRIL sni\u017euje sibeprenlimab tvorbu toxick\u00fdch akumulac\u00ed protil\u00e1tek v ledvin\u00e1ch. <\/li>\n<\/ul>\n

    Klinick\u00e9 studie ukazuj\u00ed, \u017ee jak budesonid, tak sibeprenlimab mohou sn\u00ed\u017eit hladinu b\u00edlkovin v mo\u010di o 31\u201360 %. P\u0159esto\u017ee se dlouhodob\u00e9 v\u00fdsledky st\u00e1le studuj\u00ed, tyto pokroky vy\u017eaduj\u00ed p\u0159ehodnocen\u00ed protokol\u016f ren\u00e1ln\u00edho screeningu. <\/p>\n

    Budoucnost v\u010dasn\u00e9 detekce<\/h3>\n

    Jednoduch\u00e9 testy mo\u010dov\u00fdmi prou\u017eky, kter\u00e9 se ji\u017e pou\u017e\u00edvaj\u00ed v n\u011bkter\u00fdch asijsk\u00fdch zem\u00edch, dok\u00e1\u017eou detekovat stopy krve a b\u00edlkovin, co\u017e p\u0159edstavuje levnou prvn\u00ed linii obrany. I kdy\u017e nejsou definitivn\u00ed, mohou vyvolat dal\u0161\u00ed testov\u00e1n\u00ed a mo\u017en\u00e1 i \u017eivot zachra\u0148uj\u00edc\u00ed biopsii. <\/p>\n

    Americk\u00e1 pracovn\u00ed skupina pro preventivn\u00ed slu\u017eby v sou\u010dasn\u00e9 dob\u011b aktualizuje sv\u00e1 doporu\u010den\u00ed pro screening ledvin. N\u011bkte\u0159\u00ed odborn\u00edci se stav\u00ed proti plo\u0161n\u00e9mu screeningu kv\u016fli obav\u00e1m z efektivnosti n\u00e1klad\u016f, ale rostouc\u00ed konsenzus podporuje v\u010dasnou detekci u mlad\u00fdch lid\u00ed vzhledem k \u00fa\u010dinnosti nov\u00fdch l\u00e9\u010debn\u00fdch postup\u016f. <\/p>\n

    C\u00edl je jasn\u00fd: identifikovat a l\u00e9\u010dit IgAN d\u0159\u00edve, ne\u017e dojde k nevratn\u00e9mu selh\u00e1n\u00ed ledvin.<\/strong> Dostupnost c\u00edlen\u00fdch terapi\u00ed zm\u011bnila toto ze vzd\u00e1len\u00e9 nad\u011bje na re\u00e1lnou mo\u017enost.<\/p>\n","protected":false},"excerpt":{"rendered":"

    U mnoh\u00fdch onemocn\u011bn\u00ed ledvin postupuje ti\u0161e po mnoho let a \u010dasto z\u016fst\u00e1v\u00e1 neodhaleno, dokud nedojde k nevratn\u00e9mu po\u0161kozen\u00ed. Rostouc\u00ed mno\u017estv\u00ed d\u016fkaz\u016f nazna\u010duje, \u017ee v\u010dasn\u00e1 diagnostika a intervence u IgA nefropatie (IgAN), autoimunitn\u00edho onemocn\u011bn\u00ed ledvin, m\u016f\u017ee dramaticky zm\u011bnit v\u00fdsledky pacient\u016f. Ned\u00e1vn\u00e9 pr\u016flomy v c\u00edlen\u00fdch terapi\u00edch \u010din\u00ed v\u010dasnou detekci nejen u\u017eite\u010dnou, ale potenci\u00e1ln\u011b i \u017eivot zachra\u0148uj\u00edc\u00ed. Skryt\u00e1 […]<\/p>\n","protected":false},"author":1,"featured_media":7525,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":""},"categories":[1],"tags":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/posts\/7526"}],"collection":[{"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/comments?post=7526"}],"version-history":[{"count":0,"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/posts\/7526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/media\/7525"}],"wp:attachment":[{"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/media?parent=7526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/categories?post=7526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.schooler.org.ua\/id\/wp-json\/wp\/v2\/tags?post=7526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}